Philip Lee
Algemeen Directeur bij
Profiel
Philip Lee was the founder of Senti Sub I, Inc. (founded in 2016), Cellasic Corp.
(founded in 2004), and Senti Biosciences, Inc. (founded in 2016) where he held the titles of Chief Operating Officer, Chief Executive Officer, and Chief Technology Officer respectively.
Currently, he is the Chief Executive Officer at GeneFab LLC since 2023.
Previously, he worked as Head-Cell Culture Systems at EMD Millipore Corp.
and Merck KGaA from 2012 to 2016.
Dr. Lee received his undergraduate degree from Massachusetts Institute of Technology and doctorate degrees from the University of California, Berkeley and the University of California, San Francisco.
Laatste nieuws over Philip Lee
Actieve functies van Philip Lee
Bedrijven | Functie | Begin |
---|---|---|
GeneFab LLC
![]() GeneFab LLC BiotechnologyHealth Technology GeneFab LLC develops and commercializes genetic medicines. The American company was founded in 2023 and the CEO is Philip Lee. | Algemeen Directeur | 01-08-2023 |
Eerdere bekende functies van Philip Lee
Bedrijven | Functie | Einde |
---|---|---|
SENTI BIOSCIENCES, INC. | Oprichter | 07-08-2023 |
MERCK KGAA | Hoofd Techniek/Wetenschap/O&O | 01-11-2014 |
EMD Millipore Corp.
![]() EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2014 |
Cellasic Corp.
![]() Cellasic Corp. Packaged SoftwareTechnology Services Cellasic Corp. develops a microfluidic software platform for live cell analysis experiments. The American company was founded by Philip Lee. | Algemeen Directeur | 01-04-2012 |
Senti Sub I, Inc.
![]() Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Oprichter | - |
Opleiding van Philip Lee
University of California, Berkeley | Doctorate Degree |
The University of California, San Francisco | Doctorate Degree |
Massachusetts Institute of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
SENTI BIOSCIENCES, INC. | Health Technology |
MERCK KGAA | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Senti Sub I, Inc.
![]() Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
EMD Millipore Corp.
![]() EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Commercial Services |
Cellasic Corp.
![]() Cellasic Corp. Packaged SoftwareTechnology Services Cellasic Corp. develops a microfluidic software platform for live cell analysis experiments. The American company was founded by Philip Lee. | Technology Services |
GeneFab LLC
![]() GeneFab LLC BiotechnologyHealth Technology GeneFab LLC develops and commercializes genetic medicines. The American company was founded in 2023 and the CEO is Philip Lee. | Health Technology |